Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 761

Sort by

Sort Order Select

Journal Articles

Elucidating the dynamics of integrin αIIbβ3 from native platelet membranes by cryo-EM with build-and-retrieve method

Xu Han, Zhemin Zhang, Chih-Chia Su, Meinan Lyu, Masaru Miyagi, Edward Yu, Marvin T. Nieman

Blood Adv (2025) 9 (18): 4592–4606.

https://doi.org/10.1182/bloodadvances.2025016209

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Therapeutic innovations in hemophilia: the essential role of a positive reinvestment cycle

Cedric Hermans, Glenn F. Pierce

Blood Adv (2025) 9 (18): 4631–4639.

https://doi.org/10.1182/bloodadvances.2025016497

Published: 2025

Journal Articles

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

Marie Octave, Laurence Pirotton, Emma de Cartier d’Yves, Alice Marino, Jérôme Ambroise, Martin Giera, Bruno Guigas, Audrey Ginion, Valentine Robaux, Marijke Kuijpers, Constance Baaten, Johan W. M. Heemskerk, Zoltan Nagy, Yotis Senis, Davide Brusa, Caroline Bouzin, Luc Bertrand, Christophe Beauloye, Sandrine Horman

Blood Adv (2025) 9 (18): 4553–4567.

https://doi.org/10.1182/bloodadvances.2025015796

Published: 2025

Includes: Supplemental data

Journal Articles

BaR-based cryo-EM of platelet integrin αIIbβ3

Sneha Singh, Arijit Biswas

Blood Adv (2025) 9 (18): 4654–4655.

https://doi.org/10.1182/bloodadvances.2025017161

Published: 2025

Journal Articles

Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease

Thomas David Daniel Kazmirchuk, Jiashu Wang, Loredana Bury, Emanuela Falcinelli, Calvin Bradbury-Jost, Anastasiia Koziar, Mustafa Al-gafari, Sarah Takallou, William G Willmore, Frank Dehne, Paolo Gresele, Maha Othman, Ashkan Golshani

Blood Adv bloodadvances.2025017674.

https://doi.org/10.1182/bloodadvances.2025017674

Published: 2025

Journal Articles

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

Soravis Osataphan, Rushad Patell, Mrigya Babuta, Rachel P. Rosovsky, Yohei Hisada, Charly Edmiston, Pavania Elavalakanar, Michael A. Pfeffer, Amy Bregar, Amanda Ramos, Leslie Garrett, Siyang Ren, Donna Neuberg, Gyongyi Szabo, Robert Flaumenhaft, Nigel Mackman, Meghan Shea, Jeffrey I. Zwicker

Blood Adv (2025) 9 (17): 4472–4476.

https://doi.org/10.1182/bloodadvances.2025016107

Published: 2025

Includes: Supplemental data

Journal Articles

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

Bérangère S Joly, Adrien Joseph, Raïda Bouzid, Pierre Boisseau, Thérésa Kwon, Claire Dossier, Dr, Nathalie Biebuyck, Olivia Boyer, Vassilis Tsatsaris, Jérôme Harambat, Prof, Yahsou Delmas, Olivier Moranne, Anne-Laure Sellier-Leclerc, Manon Marie, Christelle Barbet, François Provôt, Ygal Benhamou, Agnès Veyradier, Pr, Paul Coppo

Blood Adv bloodadvances.2025017638.

https://doi.org/10.1182/bloodadvances.2025017638

Published: 2025

Includes: Supplemental data

Journal Articles

Addition of ADAMTS13 Testing to Cryptogenic Stroke Evaluation: Index Case and Single-Center Screening Initial Experience

Aaron B Boothby, Jorge Nicolas Ruiz Lopez, Livia Hegerova, Dharmini Manogna, Rangaswamy Chintapatla, Samantha Harris, Gayle Teramura, David L Tirschwell, Breana Taylor, Sioban B. Keel

Blood Adv bloodadvances.2025017702.

https://doi.org/10.1182/bloodadvances.2025017702

Published: 2025

Journal Articles

Racial disparities in the management of deep vein thrombosis from a nationwide hospitalization study

Jayalekshmi Jayakumar, Manasa Ginjupalli, Nikhil Vojjala, Davin Turku, Fiqe Khan, Srijani Thannir, Aju Kalaivani Babu, Srinishant Rajarajan, Tijin Ann Mathew, Arya Mariam Roy

Blood Adv (2025) 9 (17): 4364–4367.

https://doi.org/10.1182/bloodadvances.2025016171

Published: 2025

Journal Articles

Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome

Blood Adv (2025) 9 (16): 4323–4335.

https://doi.org/10.1182/bloodadvances.2024015076

Published: 2025

Includes: Supplemental data

Journal Articles

SGLT2i-associated erythrocytosis: closing the evidence gap

Benjamin Chin-Yee, Cyrus C. Hsia

Blood Adv (2025) 9 (16): 4321–4322.

https://doi.org/10.1182/bloodadvances.2025016967

Published: 2025

Journal Articles

Diagnosis of von Willebrand Disease

Mackenzie Bowman, Paula D. James

Blood Adv bloodadvances.2025016485.

https://doi.org/10.1182/bloodadvances.2025016485

Published: 2025

Journal Articles

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

Sirui Ma, Yu-Cheng Chang, Cho Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader

Blood Adv bloodadvances.2025017523.

https://doi.org/10.1182/bloodadvances.2025017523

Published: 2025

Includes: Supplemental data

Journal Articles

Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation

Edouard Machenaud, John W. Weisel, Rustem I Litvinov, Chandrasekaran Nagaswami, David N Ku

Blood Adv bloodadvances.2025017354.

https://doi.org/10.1182/bloodadvances.2025017354

Published: 2025

Includes: Supplemental data

Journal Articles

Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets

Alexis N. Smith, Hammodah R. Alfar, Smita Joshi, Daniëlle M. Coenen, Joshua Lykins, Isabelle C. Becker, Brittany E. Dong, Harry Chanzu, Chi Peng, Kanakanagavalli Shravani Prakhya, Linda Omali, Irina D. Pokrovskaya, Brian Storrie, Joseph Italiano, Sidney W. Whiteheart

Blood Adv (2025) 9 (16): 4111–4125.

https://doi.org/10.1182/bloodadvances.2024014870

Published: 2025

Includes: Supplemental data

Journal Articles

The balancing act after pediatric venous thromboembolism

Hilary Whitworth, Leslie Raffini

Blood Adv (2025) 9 (15): 3905–3906.

https://doi.org/10.1182/bloodadvances.2025016871

Published: 2025

Journal Articles

Exorcizing the devil of factor VIII inhibitors

Paul C. Moorehead

Blood Adv (2025) 9 (15): 3716–3717.

https://doi.org/10.1182/bloodadvances.2025016643

Published: 2025

Journal Articles

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Samira Glaeser-Khan, Satoko Ito, Manraj Sra, Rhys Richmond, Robert D Bona, Harlan Krumholz, Stacy E Croteau, Adam Cuker, George Goshua

Blood Adv bloodadvances.2025016822.

https://doi.org/10.1182/bloodadvances.2025016822

Published: 2025

Includes: Supplemental data

Journal Articles

Phosphorylation at Y317 on Syk Negatively Regulates Both ITAM and hemITAM-Mediated Signaling and Function in Platelets

Manal Elzoheiry, Carol A Dangelmaier, Dhruv N Vajipayajula, Monica N Wright, Alexander Tsygankov, Satya P. P Kunapuli

Blood Adv bloodadvances.2025016714.

https://doi.org/10.1182/bloodadvances.2025016714

Published: 2025

Includes: Supplemental data

Journal Articles

Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTP.

Tim Postmus, Robin Jansen, Paul Kaijen, Floris P.J. van Alphen, Carmen van der Zwaan, Arie J Hoogendijk, Paul Coppo, Bérangère S Joly, Agnès Veyradier, Pr, Karen Vanhoorelbeke, Gerry A.F. Nicolaes, Jan Voorberg

Blood Adv bloodadvances.2025017193.

https://doi.org/10.1182/bloodadvances.2025017193

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Elucidating the dynamics of integrin αIIbβ3 from native platelet membranes by cryo-EM with build-and-retrieve method

Therapeutic innovations in hemophilia: the essential role of a positive reinvestment cycle

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

BaR-based cryo-EM of platelet integrin αIIbβ3

Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

Addition of ADAMTS13 Testing to Cryptogenic Stroke Evaluation: Index Case and Single-Center Screening Initial Experience

Racial disparities in the management of deep vein thrombosis from a nationwide hospitalization study

Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome

SGLT2i-associated erythrocytosis: closing the evidence gap

Diagnosis of von Willebrand Disease

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation

Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets

The balancing act after pediatric venous thromboembolism

Exorcizing the devil of factor VIII inhibitors

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Phosphorylation at Y317 on Syk Negatively Regulates Both ITAM and hemITAM-Mediated Signaling and Function in Platelets

Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTP.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only